pcJ News Briefs – Sunniva Inc. has filed a preliminary prospectus qualifying the issue of common shares underlying its previously issued special warrants.
Sunniva has applied to list its common shares on the Canadian Securities Exchange (CSE).
Sunniva issued 983,753 special warrants, in three tranches on June 27, 2017, on August 9, 2017 and on September 19, 2017, at $6.75 per special warrant to raise gross proceeds of $6,640,332.75. The financing was led by Canaccord Genuity Corp. with Beacon Securities Limited.
The prospectus will also qualify the issuance of common shares underlying the corporate finance special warrants and broker warrants issued in connection with financing.
As of September 25, 2107, Sunniva had 25,528,663 common shares issued and outstanding. Leith Pedersen and Dr. Anthony F. Holler are two largest shareholder controlling 4,678,251 (18.33%) and 2,882,612 (11.29%) common shares respectively.
photo credit: Sunniva
News Release
SUNNIVA INC. FILES PRELIMINARY PROSPECTUS
CALGARY, ALBERTA – September 26, 2017 – Sunniva Inc. (“Sunniva” or “the Company”), a North American provider of medical cannabis products and services, has filed its preliminary prospectus with the securities regulatory authorities in British Columbia, Alberta and Ontario to qualify the issue of common shares underlying its previously issued special warrants. The financing was led by Canaccord Genuity Corp. with Beacon Securities Limited. The Company has applied to list its common shares on the Canadian Securities Exchange (“CSE”). Listing is subject to the Company fulfilling the listing requirements of the CSE.
Sunniva is a vertically integrated medical cannabis company in Canada and California committed to delivering safe, low-cost, high-quality products and services at scale. The Company plans to work in pursuit of better cannabis products free of pesticides, better greenhouse production design and performance, better patient and doctor access to cannabis education, and better therapeutic delivery devices.
Sunniva currently operates through its four wholly-owned operating subsidiaries:
CP Logistics, LLC (“CPL”) – Through CPL, Sunniva is developing the Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. Sunniva Campus is planned in two phases and has been designed to comply with Current Good Manufacturing Practices (cGMP). Phase one is designed to be a 324,000 sq. ft. facility. The total campus is expected to produce over approximately 120,000 kg of premium medical cannabis a year after Phases 1 and 2 are complete. At this facility, products will be produced free from the pesticides commonly used within today’s industry.
Sunniva Medical Inc. (“SMI”) – SMI is a late stage applicant under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) and is in the review stage. SMI is designing the Canadian Sunniva Campus, a purpose-built greenhouse facility to be located in Oliver, British Columbia. Phase one is designed as a 400,000 sq. ft. facility.
Natural Health Services Ltd. (“NHS”) – NHS owns and operates a network of medical clinics in Canada specializing in medical cannabis under ACMPR. NHS connects patients with safe and effective medical cannabis products through licensed producers. In-house physicians specializing in the endocannabinoid system provide expert consultation, education, and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS’ proprietary technology infrastructure assists physicians, patients, and licensed producers to comply with the rules of Health Canada.
Full Scale Distributors, LLC (“FSD”) – FSD, and through its brand, Vapor Connoisseur, is a provider of custom, private-label vaporizers. FSD currently serves the needs of over 80 brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative vaporization devices. Products are tailored to client needs, ensuring both safety and reliability.
This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale or any acceptance of an offer to buy, any securities in any province or territory of Canada prior to the time a receipt for the final prospectus or other authorization is obtained from the securities commission or similar authority in such province of territory. A copy of the preliminary prospectus is available on SEDAR at www.sedar.com.
Information contained in the preliminary prospectus may not be complete and may be amended. This release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About Sunniva Inc.
Headquartered in Western Canada, Sunniva Inc. (formerly Sunniva Holdings Corp.) is a vertically integrated medical cannabis company committed to improving the quality of human life through its planned delivery of low cost, high-quality medical cannabis and better access to physician-led therapies and delivery methods. Sunniva brings legitimacy to the nascent medical cannabis market through state-of-the-art technology, strict regulatory compliance, safety and education. Sunniva operates in Canada and California and plans to cultivate, produce and distribute a broad range of solutions focused on patients’ needs. Sunniva operates through its wholly owned subsidiaries – CP Logistics, Sunniva Medical, Natural Health Services and Full-Scale Distributors.
Contact Information
Dr. Anthony Holler
Co-founder, Chairman and Chief Executive Officer
587-430-0680
ir@sunniva.com